The 15 minute video (see below) is hosted by Chris Dixon, veterinary ophthalmologist and director at Veterinary Vision Ophthalmic Referrals, who discusses things to consider when examining a patient with an ocular disorder. He offers practical advice on how to perform an ocular examination, including tips on how to use an ophthalmoscope effectively, examining the ocular structures including the front eye, distant direct examination, indirect examination and close direct examination.
Chris said: "This series of videos aims to help vets learn how to perform the fundamental techniques of ophthalmic examination, hopefully enabling them to spot potentially degenerative conditions earlier. The second video in particular delves into practical tips that vets can use within practice. The videos have been created in partnership with Bayer as part of their ongoing commitment to training, and aim to help ensure that chronic conditions, such as keratoconjunctivitis sicca (KCS), or dry eye, are diagnosed and treated early."
The veterinary practice waiting room display materials are designed to help practices educate dog owners on the signs and management of Dry Eye in the hope that the condition may be diagnosed and treated earlier and to emphasise the importance of ongoing treatment and management.
Hannah Watts, Group Product Manager at Bayer said: "It is important that dog owners with a predisposed breed are aware that their pet may be at risk of developing Dry Eye and are aware of the symptoms. Annual testing in at risk breeds for Dry Eye is recommended to help reach an early diagnosis and optimise the chances of a successful treatment outcome."
The Dry Eye practice display materials are available to order via the Bayer Vet Centre www.vetcentre.bayer.co.uk. Alternatively, ask your Bayer rep for more details.
fVtqNMj35c8
According to the company, participating practices more than doubled the number of blood pressure checks they conducted, within 12 months.
The CVS’ clinical improvement project initially looked at how effective its first opinion small animal practices were in screening older cats for hypertension.
In line with the veterinary industry norm, it found that less than two per cent of cats over the age of seven were receiving an annual blood pressure check.
This initial research also found that the common barriers to conducting blood pressure checks by vets and veterinary nurses in practice were due to time constraints, availability of equipment and simply remembering to discuss blood pressure checks with owners.
Each CVS site chose two people to lead the initiative at their site, to aid communication and delivery.
A document was created to help, providing background, aims, summary of resources and planning sections.
Contributory factors preventing delivery of blood pressure checks were outlined and practices were encouraged to identify additional barriers and resources needed.
A suite of resources were then produced to support the practice team - from reception to veterinary surgeons - in improving annual blood pressure check rates.
The resources included new clinical frameworks and veterinary guidelines on how to treat hypertension; in-practice educational resources to highlight the benefits of hypertension screening and information sheets and blood pressure diaries to help clients manage their pets condition.
To upskill and develop colleagues in how to identify and treat hypertension and resulting conditions, a collection of training materials was created and training sessions held.
These included a series of webinars which explained why hypertension is important to identify, how to overcome common challenges encountered when looking for hypertension in cats, how to use the ophthalmic exam to help diagnose hypertension and how to treat hypertension.
Three in-person CPD days were hosted with the support from Ceva six months into the project where feline specialists Sarah Caney and Samantha Taylor shared the latest evidence base in this field and practices were encouraged to share barriers, queries and tips, so that ideas could be taken away to make blood pressure screening a simpler process in practice.
Practices were also encouraged to organise lunch and learn CPD sessions, to share best practice and generate discussion within their team.
In addition, a website was created to host all resources in one place, including webinars, clinical frameworks, client resources, a discussion forum and data.
An audit of each participating practice’s blood pressure check data was conducted at the start of the project.
Results were then shared with each participating practice every month - including the total number of blood pressure checks performed each month and the percentage of cats over the age of seven who had an annual blood pressure check.
Twelve months after its nation-wide launch, results reveal that the number of blood pressure checks have more than doubled (110%) within participating CVS practices and an additional 5,984 blood pressure checks have been performed year on year.
A number of practices were able to implement systems that allowed them to perform over 40 blood pressures each month.
The number of cats on amlodipine (the first choice medication to treat hypertension in cats) increased by 303 patients year-on-year, hinting many more cats had been diagnosed with hypertension.
Kate Allgood, Hub Clinical Lead at CVS who was responsible for the hypertension clinical improvement project, said: “There is a huge benefit in treating hypertension.
"No one wants to see a cat suddenly become blind due to hypertension that wasn’t recognised in time.
"So many associated longer-term feline complications and conditions can be avoided if annual blood pressure checks in cats over the age of seven are routinely performed.
"Increasing blood pressure screening is not a simple task though, and this focus has allowed space and time for practices to give this topic the recognition it deserves; to identify and implement systems that make it easier to identify patients at risk, discuss with clients and perform these checks with ease.
"We have created a robust clinical structure, produced some easily accessible materials and supported our practices to make small and simple changes that add up.
"Our practices have done an outstanding job at delivering this project to date and I look forward to seeing what can be achieved in the future. We strongly believe that this work will contribute towards providing some of the best clinical care for cats in the veterinary profession.”
Intervet / Schering Plough Animal Health has launched Leventa, an easily administered once daily, liquid treatment for canine hypothyroidism.
Leventa is a low volume liquid formulation of levothyroxine sodium which provides the thyroxine needed by dogs with hypothyroidism. The company says it is readily accepted.
Until now, thyroxine has only been available in a tablet format. Leventa comes in a single presentation 30 ml bottle with a dosing syringe suitable for all weights of dogs, allowing straightforward storage and stock control.
Leventa enables accurate dosing and easy dose titration. The ready-to-dispense pack avoids time-consuming tablet dispensing and handling of medications.
In addition to the practical compliance benefits of the liquid format, Intervet / Schering Plough says Leventa also offers excellent bio-availability1. In trials, 79% of dogs stabilised on the once daily starting dose of 20g/kg avoiding lengthy stabilisation2.
Vicki Winslet, Veterinary Advisor at Intervet / Schering Plough said: "One of the greatest challenges faced by vets for effective treatment is owner compliance. Leventa overcomes this issue with a simple syringe dose replacing the need for tablets of varying sizes and quantities."
One of the most common endocrine disorders in dogs but difficult to diagnose, hypothyroidism can lead to a variety of issues including weight gain, lethargy and coat problems (including dullness, loss or thinning). It can also cause insulin resistance in diabetic dogs.
The launch of Leventa further extends Intervet / Schering Plough's endocrine portfolio which includes Caninsulin, developed for the treatment of diabetes in small animals and Vidalta, a once daily treatment for hyperthyroidism in cats which is already proving extremely popular with the profession.
For further information, please contact your Intervet/Schering-Plough account manager or telephone the company's Veterinary Support Group on 01908 685685.
1. Le Traon G, Burgaud S, Horspool LJ. (2008) Pharmacokinetics of total thyroxine in dogs after administration of an oral solution of levothyroxine sodium. J Vet Pharmacol Ther 31:95-101.2. Gommeren K, Benchekroun G, Brennan S.F, Burgaud S, Daminet S, Horspool L.J.I, Le Traon G, Rosenberg D, Mooney C.T (2008) A novel L-thyroxine solution is a safe and effective once daily treatment for canine hypothyroidism. In:Proceedings BSAVA congress 2008 , 3-6 April Birmingham, UK pp487-488
The RCVS Disciplinary Committee has reprimanded a veterinary surgeon for submitting a certificate of Clinical Inspection for Veterinary Inspectors ("TB52") for tuberculin tests he had undertaken on cattle, despite knowing that he had not fully complied with the standard operating procedures (SOP) for these tests.
At the outset of the three-day hearing, John Wilson admitted that, when acting as an Official Veterinarian (OV) he had not carried out tuberculin tests on cattle at a Wiltshire farm on 19 May 2011 strictly in accordance with the SOP required by the Animal Health and Veterinary Laboratories Agency (AHVLA), an executive agency of Defra.
The admitted shortcomings were that on 19 May, the second day of testing, Mr Wilson had failed to confirm the identity of all the animals, failed to inspect the animals digitally (ie using his hands) and had not measured the fold of skin at the injection site of all the animals. The College argued that this was contrary to the directions of the AHVLA and, in subsequently signing the TB52 certificate, he was either dishonest or should have known that the certification was incorrect. Mr Wilson admitted that he ought to have known the certification was incorrect but denied dishonesty, because he believed that he had conducted the test in a satisfactory manner and had correctly identified all the reactors in the herd.
Mr Wilson was a veterinary surgeon of over 40 years experience and unblemished record, and the Committee found his account of events to be accurate and honest. He said the farm involved was unprepared and test arrangements were chaotic, with poor handling facilities, and he would have been concerned for the safety of the animals and their handlers if he had complied fully with the SOP. He had advised the farmer to delay the test but his advice was rejected.
The Committee accepted that the testing had been carried out under exceptional and difficult circumstances. It noted that Mr Wilson had identified a reactor and taken appropriate actions, knowing that the outcome would be the quarantining of the whole herd. He had made no financial or other gain, other than the nominal fee charged for the work. Although failing to comply with the SOP fell short of what was expected of a veterinary surgeon, because of these circumstances, and as he had acted in what he considered to be the best interests of the animals and personnel, these actions did not amount to serious professional misconduct.
The Committee found that, even allowing for these difficulties and concerns, in signing the TB52 certificate a few days later, without any qualification, Mr Wilson ought to have known that it was incorrect, and his actions fell far short of the standards expected of the veterinary profession. They did not however find that he had been dishonest.
The Committee stressed the importance attached to accurate and reliable certification, in maintaining the confidence of the public and the profession, and in ensuring animal welfare.
Professor Lees, chairing and speaking on behalf of the committee said: "The Committee is aware, as confirmed by AHVLA, that this is a single, isolated event and the first offence in some 40 years of the Respondent working as a LVI [local veterinary inspector] or OV. After considering all the mitigating factors.and, given the exceptional circumstances of this specific case, the decision of the Committee is to reprimand Mr Wilson."
Bayer Animal Health has announced the launch of a new campaign which plays on our anthropomorphic nature to drive owners into practice for worming.
As part of the campaign, the company has enrolled the behaviour specialist and author Sarah Whitehead to oversee a video analysis of the behavioural interaction between a small number of dogs and their owners. The results will be used to make an educational film for pet owners which helps them better understand their pet's emotions and behaviour.
Tracey Dawson, Group Product Manager at Bayer Animal Health said: "We want owners to really understand the importance of health on their dog's happiness and behaviour, whilst reminding them to worm their pet at least four times a year. Our ground breaking research will make owners feel like real-life Dr Doolittle, as they will better understand their pet's emotions and actions, highlighting the importance of keeping their dogs healthy, happy and worm-free."
In order to prompt owners to worm their dog more frequently, Bayer has also launched a free SMS/email worming reminder service available at www.drontal.com. In addition, there'll be a new CPD section for SQPs on the website in the summer..
Bayer is also developing 'Worm Reminder' toolkits for veterinary practices, including a press release template, infographics, and video report of the research findings to further promote the importance of worming frequently. For more information, talk to your Bayer representative.
Medivet has announced that the Pilgrims Veterinary Clinics based in Dartford and West Kingsdown have become the 100th and 101st practices to join the Medivet Veterinary Partnership
Arnold Levy, Managing Director of Medivet said: "We are delighted to welcome the Pilgrims group. Medivet was founded in 1986, and we have been growing steadily ever since. Our model is based on acquisition or partnership with existing practices. That means we are still entirely vet owned and vet managed - and I strongly believe this traditional partnership model is the reason for our success."
He added: "We invest alongside our partner practices. We share the cost of investment for new equipment, and we share the profits. This has been a consistently successful approach for us. It's given our group the resilience to thrive whatever the competition, or the state of the economy."
For the survey, 565 respondents ranked their levels of concern about different aspects of veterinary life that may be affected by coronavirus.
The top concerns were:
In addition, 42% were very or quite concerned about contracting Covid-19 in their workplace, rising to 55% amongst those working in mixed practice and 50% in small animal/exotic practice.
Respondents were more concerned about stress and burnout amongst their colleagues (67% very or quite concerned) than the impact on themselves (45%), but more than half (58%) of small animal/exotics vets reported being concerned about their own stress and burnout. Managers and employees reported higher levels of concern around stress and burnout than business owners and those who are self-employed.
When it comes to employment, the profession is a bit more optimistic. 23% of respondents are not at all concerned about job security in the veterinary sector, with 43% a little concerned and 31% very or quite concerned. Equine vets (45%) and charity vets (64%) are very or quite concerned about job security in their own sectors, against an average of 23% across all areas of work.
However, 95% of respondents had some level of concern (a little, quite or very) about the potential impact of a recession on the veterinary sector, with government, equine and charity vets most concerned.
The findings will be used to inform BVA’s work on supporting the veterinary profession as the pandemic continues.
BVA President James Russell said: “Although this is just a snapshot survey, it tells us a lot about how our colleagues are feeling six months on from the national lockdown. It paints a worrying, but not surprising, picture about the health and wellbeing of a profession that has worked incredibly hard and in very difficult circumstances this year.
“I’m incredibly proud of the way the profession has adapted to working safely during Covid-19, but we know that it has taken its toll, for example with consults taking longer, needing to cover staff shortages, and dealing with anxious clients.
“BVA also shares the profession’s concerns about the impact on students and new graduates. EMS is the jewel in the crown of UK veterinary teaching and it’s frustrating that opportunities to gain practical training have been hampered by the Covid restrictions. The issue is at the top of our agenda with the RCVS and Vet Schools Council to make sure we can collectively support the next generation of vets through this difficult time.
“As the UK is braced for the second wave, we know we are much better prepared and far more able to work safely to do our bit to tackle the spread of coronavirus. But it’s vital that we continue to support one another, as well as continuing the spirit of collaboration with neighbouring practices that helped us get through the height of the pandemic.
The snapshot survey on Covid-19 is available to view at: https://www.bva.co.uk/media/3781/voice-covid-survey-2020-results.pdf
Fort Dodge, which supplies Bluetongue vaccine in continental Europe, has licensed its cattle vaccine in the UK and is now launching the product onto the UK market.
The company has already won and met tenders from several European governments, including France, Spain, Italy, Portugal Germany, Switzerland, Belgium and the Czech Republic for its Zulvac 8® Bovis vaccine and says it is the only international company to have produced vaccines for the most commonly occurring serotypes of the disease including 8, 4 and 1.
Approved by the VMD with a Provisional Marketing Authorisation, Zulvac 8 is available in 50 dose and 10 dose packs. The key claims are active immunisation against Bluetongue serotype 8 of cattle from 2.5 months old and a significant reduction of viraemia.
The vaccine is administered in 2 x 2 ml doses at three week intervals given by intra muscular injection and the product is supported by a fixed 2ml multidose applicator with Sterimatic needle protector and cleaning system to ensure accurate dosing and hygienic conditions.
John Hanley, Managing Director of Fort Dodge UK, said: "We were first to market with our Zulvac 8 product in three European countries and have received an Award for Agricultural Merit from the Spanish Government for our work in Bluetongue control. Following the licensing of Zulvac 8 Bovis in the UK we now have the opportunity to launch the product onto the UK market.
"In terms of pricing, Zulvac 8 is competitive per dose against other products in the market and it is supported by the experience gained in Europe with millions of animals already vaccinated. We're delighted that the VMD have authorised the vaccine and believe its availability can play a key role in protecting the UK's cattle from this dreadful disease."
The product is authorised for use by cattle farmers in the protection zone only, and will require veterinary prescription. Farmers can administer the vaccine to their cattle and the 2ml intra-muscular injection will be an advantage in aiding administration especially when used with Zulvac Bovis applicator with sterimatic needle protector and cleaning system.
The first batches will be available from veterinary wholesalers from week commencing 22nd September 2008.
A new study1 lead by led by Dr Séverine Tasker at the University of Bristol's School of Veterinary Sciences and published in the journal Clinical and Vaccine Immunology (CVI), has shown that cats previously infected with the blood-borne bacteria M. haemofelis develop immunity from re-infection.
Haemoplasmas are a group of blood borne bacteria found in a wide range of mammals, including domestic and wild cats, and can cause severe anaemia. The findings of the new study have significantly advanced researchers' knowledge of immunity for these pathogens.
Information about the immune responses that occur in animals following haemoplasma infection is relatively unknown, largely due to the fact that researchers struggle to study these bacteria as they are unable to grow them in the laboratory. Antibiotics do not consistently clear infection and without correct treatment the anaemia can be fatal. Recently haemoplasma associated anaemia has been reported in a human too.
The aim of the study was to determine whether cats who had previously recovered from M. haemofelis infection were protected from re-infection. The researchers found that they were, representing a significant advancement in scientists' knowledge of immunity for haemoplasma infections.
The exact methods of protective immunity could not be clearly identified despite extensive investigations, but the study's results suggest that a vaccine, using a weakened form of the bacteria, may offer protection against haemoplasma infection.
Séverine said: "This is the first study to demonstrate protective immunity against M. haemofelis reinfection and it provides important information for a possible future haemoplasma vaccine.
"Our findings could help prevent the disease in cats and could also be of particular importance to farm animal species where haemoplasma infections can cause huge financial losses."
The study recommends future research should explore whether the bacterial animal infection could be transmitted to humans and how the immune system targets the pathogen.
Reference
The 'Tea-Time Training' webinar will be led by Animalcare’s Senior Veterinary Manager, Felicity Caddick.
Tea-Time Training was launched by Animalcare in April to support veterinary surgeons and nurses keep up their CPD. The webinars are short, free, refresher-style training sessions, designed to be enjoyed over a cup of tea.
Animalcare Product Manager James Beaumont said: “A missing microchipped pet is much more likely to be reunited with its owner than an animal which has not been microchipped. National Microchipping Month is a great opportunity for practices to remind clients of the benefits of microchipping and, in doing so, to strengthen their relationships with clients – relationships which are even more important given the difficult times we’re living through.”
To register for ‘4 Essentials for Successful Microchipping’, visit https://mailchi.mp/animalcare/tea-time-training.
According to the Spring 2022 Voice of the Profession survey, one in four cats (24%) seen in practices are not having all of their welfare needs met.
The issues identified by vets as the most pressing at their practice were:
Participating practices will learn about dental disease pathophysiology and diagnosis, gain insights in pet owner behaviour and learn how to increase client engagement while implementing a dental home care plan.
Animalcare has also made available free social media packs and waiting room materials to help educate clients on pet dental health.
Will Peel, Marketing Manager at Animalcare said: ‘We know that UK veterinary surgeons consider dental disorders to be one of the most important health related welfare issues currently affecting UK dogs.
"We’ve introduced our CPD sessions to help the entire veterinary team learn more about dental disease and to help them educate their clients about implementing an at home dental regime which works for them and their pets.'
To book your Lunch and Learn or request a social media pack and other materials, contact your local Animalcare territory manager or email animalcare@animalcare.co.uk.
Three members (one vet, one new grad and one nurse) are being sought to join a new engagement group tasked with raising awareness of the importance of CPD for veterinary surgeons and nurses, supporting members in how to reflect on their CPD as a way of consolidating learning, and considering plans for how the benefits of CPD and the VetGDP can be communicated to the professions.
The group will also oversee and update CPD and VetGDP guidance documents, as well as overseeing updates to the VetGDP Adviser and VetGDP Peer Reviewer training and guidance.
RCVS Council member Dr Olivia Cook MRCVS will be chairing the group.
She said: “The Engagement Group has been set up in recognition that, although the majority of the professions are engaged with meeting their CPD requirements and completing the VetGDP, there are still those who feel confused about the requirements or remain uncompliant for other reasons, and we would like very much to help them.
“Therefore, this is an exciting opportunity for anyone who wants to play an active part in advancing veterinary standards by ensuring that as many members of the professions as possible have the benefits of lifelong learning in their own practice and their ongoing work for animal health and welfare. In doing so they will help grow public confidence in the professions.
“From the VetGDP perspective, we’re particularly keen that there’s a strong peer-to-peer element, so that those who are doing the VetGDP, or have just recently completed it, are using their recent experience and understanding to evolve the policy and drive engagement.”
Applicants who are interested will have until Friday 30 August to apply to become members of the CPD and VetGDP Engagement Group and are invited to send a concise email to CPD@rcvs.org.uk explaining their experience and how they feel that can contribute to work of the committee.
The RCVS is looking for two Advanced Practitioners working in practice who have completed a designated CertAVP qualification to join the Certificate in Advanced Veterinary Practice (CertAVP) Subcommittee to help actively advance the standards and policies of the RCVS CertAVP.
Applicants who are interested also have until Friday 30 August to apply to become members.
Applicants are invited to send an email to certavp@rcvs.org.uk with a summary of their experience and what skills and knowledge you feel that you can bring to this committee.
Finally, the College is also looking to recruit examiners for the Statutory Membership Examination, from 2025 onwards.
Examiners need to have been Members of the RCVS for a minimum of three years and be familiar with the day one competences for new registrants and the standards expected of final year students and new graduates. Experience as an assessor or examiner is preferred, although not essential as training will be provided. The College is looking for examiners with knowledge across a range of species domains including equine, veterinary public health, farm and small animal.
Contact Jenny Soreskog-Turp, RCVS Postgraduate Lead, on j.soreskog-turp@rcvs.org.uk
Following a nationwide search to find the UK’s top veterinary professionals for 2008 and judged by an independent panel of experts, Petplan has announced the winners of the prestigious Petplan Veterinary Awards, which were presented at a black-tie gala dinner on 3rd April in Birmingham.
The winners of the awards, which acknowledge achievement in the veterinary world, are: VET OF THE YEAR Brian Faulkner of the Melton Veterinary Surgery, Woodbridge Brian’s understanding and compassion for his clients’ pets impressed judges. He receives literally hundreds of cards and letters expressing appreciation for his efforts, care and dedication and can deliver devastating news with the gentlest touch. Brian, often known as ‘Uncle Brian’ by his clients, continuously goes over and above the call of duty and fully deserves the title ‘Vet of the Year 2008’.
VET NURSE OF THE YEAR Louisa Baker of the Priors Leaze Veterinary Centre, Chichester The judges believe that Louisa is an excellent role model for those interested in veterinary nursing. She spends quality time supporting and training those around her and has the unusual ability to win people over instantaneously with her kind and gentle manner. Louisa shows a deep-rooted compassion for owners and their animals and truly deserves the title of ‘Veterinary Nurse of the Year’. According to her clients, friends and colleagues she is “one in a million”.
VET RECEPTIONIST OF THE YEAR Margaret Gait of Cinque Ports Veterinary Associates, Lydd Margaret has worked at Cinque Ports Veterinary Associates for 15 years, and is now a popular, much loved member of the local community. She is a hard working, conscientious team player, who isn’t afraid to get her hands dirty – and often stays late to help with emergencies or to clean up after surgery. She constantly goes the extra mile and Petplan is delighted to name her ‘Vet Receptionist of the Year’.
VET PRACTICE OF THE YEAR Orwell Veterinary Group, Ipswich Orwell Veterinary Group was described as having a number of ‘remarkable’ qualities by the panel of judges. The high level of customer care, staff’s dedication to continued professional development and the emphasis on developing strong client relationships were all described as exceptional.
Charles Bagnall, the practice owner and practicing vet, explains: “I am very proud of what my brother, I and our dedicated team have achieved over the past 14 years – we have built a well recognised and respected multi-centred practice and accredited veterinary hospital, while still providing friendly, professional and personal care.”
SPECIAL RECOGNITION AWARD In addition to these awards, a Special Recognition Award, voted for by the general public, was also presented to Matt Brash who has become a popular TV vet. More recently, Matt’s ITV series, ‘Zoo Vet’ and ‘Zoo Vet at Large’ have received widespread appeal the world over.
Matt explains: “I am absolutely delighted to have received this award for my work in the
A survey carried out by Intervet/Schering-Plough Animal Health to launch Plerion, a chewable, flavoured wormer for dogs, has shown that most UK dog owners turn to their vet rather than a pet shop for advice on worming.
Over 83% of owners who took part in the survey said they follow their vet's advice on worming whilst fewer than 8% would follow the advice of their local pet shop. 63% choose to buy wormers from their vet against 35% buying wormers from a pet shop or online pharmacy.
Survey participants understood the importance of carrying out a regular worming programme with almost 80% stating that a dog should be wormed every three to four months. However, some owners cited forgetfulness as a reason for not worming their pet regularly and expressed a need for a reminder from their local vet practice.
Almost 85% of those who took part in the survey believed that not all wormers provide the same level of protection and almost 75% said that vet recommendation is the reason they purchase a specific brand of wormer. 94% of owners are aware that worms can affect people as well as dogs.
The survey revealed that 1 in 5 owners experienced difficulty in administering a complete dose due to their dog spitting out part or the entire tablet.
Intervet/Schering Plough says that Plerion should help reduce compliance issues; its innovative and tasty soft chew formulation meaning that most dogs will take it right out of the hand.
Sarah-Jane Minter, marketing manager at Intervet/Schering-Plough said: "When developing Plerion we knew it was essential to launch a product that made life easier for dog owners by being easy, and even fun, to administer as this would increase the likelihood of owners sticking to a regular worming programme. We are delighted by the feedback we are receiving from owners who report their once fussy dogs are taking the flavoured, chewable Plerion tablets as though they were treats."
Plerion is available in two tablet sizes that provide a combination of Pyrantel, Praziquantel and Oxantel which, the company says, gives effective treatment for the major endoparasites in a single dose including tapeworm Echinococcus multilocularis, as required by the Pets Travel Scheme (PETS).
For further information, please contact your local Intervet/Schering-Plough Veterinary Business Manager or phone the company's Veterinary Support Group on 01908 685685.
Merial Animal Health has announced that the duration of immunity for the tetanus component of Proteqflu-Te has been extended to 2 years.
Merial's Veterinary Technical Manager Kevin Whelan said: "This is a welcome new addition to the label claims for this advanced vaccine, which is the only equine flu vaccine in the UK to contain a recently updated influenza virus strain. The updated strain, innovative canarypox vector technology and now the extended tetanus duration of immunity claim make the vaccine an excellent choice for vets in the UK"
Merial says Proteqflu-Te can now be used on an alternate year basis in combination with the company's other flu vaccine, Proteqflu, which does not contain tetanus toxoid. The one year duration of immunity for the influenza component remains unchanged.
Please contact your local Merial Representative or the Merial Technical Support line on 0870 6000 123 for further information.
The Office of Fair Trading has concluded that it has no grounds to take action against IDEXX Laboratories Limited following an investigation into alleged abuses of a dominant position in the veterinary diagnostic testing sector.
The OFT opened its investigation in November 2010 after it received a complaint alleging that IDEXX was abusing a dominant position in the market for the supply of in-clinic pet testing equipment in order to foreclose competition.
The conduct assessed by the OFT included alleged practices of:
The full reasoning for the OFT's conclusion, including details of the methodologies used by the OFT to assess potential theories of harm relating to alleged mixed bundling (also known as multi-product rebates) and alleged predatory pricing in systems markets, is available from the OFT's website, here.
Public Health England (PHE) is urging veterinary surgeons, nurses, other healthcare professionals and the public to become Antibiotic Guardians by visiting antibioticguardian.com and pledging to make better use of antibiotics, to help make sure they work now and in the future.
The website first asks users to choose whether they would like to make a pledge as a member of the public or as a healthcare professional or leader.
Those who pledge as a Healthcare Professional > Veterinary Practitioner can select one of the following pledges:
Those who pledge as a member of the public can elect to do so as an adult, a family member, a pet owner or a farmer.
The available pledges change according to category and those who respond will be asked if PHE can follow-up to confirm they did keep their pledge.
The campaign forms part of activities that support European Antibiotic Awareness Day (EAAD). Dr Diane Ashiru-Oredope, Lead for EAAD 2014 at Public Health England, said: "Everybody can help to tackle antibiotic resistance and we really urge people to help us do this. There is a lot to be done but we can start by making inroads into inappropriate prescribing.
"There are 2 elements to this. One is that we need patients to not always expect to receive an antibiotic for those self-limiting illnesses which are typically caused by viruses. This generally includes those where the symptoms include coughs, runny noses, muscle aches and fever. And the other is for GPs not to feel pressurised into prescribing antibiotics when they aren't really necessary.
"Community pharmacists and their teams also have a key role and should be seen as the first port of call for many winter illnesses caused by viruses. They can also help to manage patients' expectations by explaining the normal duration of these symptoms, what warning signs to look out for and providing effective over the counter treatments that will help relieve the symptoms.
Nicholas Brown, President at the British Society for Antimicrobial Chemotherapy (BSAC), said: "Recently published research in BSAC's Journal, Journal of Antimicrobial Chemotherapy, confirms that despite government recommendations to reduce prescribing for viral illnesses there are still many GPs who do this. Of course GPs don't want their patients to feel unwell but there are many medicines which are available over-the-counter which can really help to reduce symptoms and make people feel better.
"We want to encourage everyone to self-treat as much as possible when it is safe and appropriate to do so. By using antibiotics only when they are needed we can all help to make sure that we keep our antibiotics working for everyone in the future.
"Antibiotic resistance is one the biggest threats to public health and PHE is delivering 4 key aspects of the 5-year UK strategy to help combat antibiotic resistance. These are improving infection prevention and control practices to reduce the number of infections in patients; optimising prescribing practice, improving professional education, training and public engagement and enabling better access to and use of surveillance data."
Children learn lots of important lessons about life, sickness and death from animals and veterinary practitioners. There seems to be an important role here for the profession to educate adult animal owners why antibiotics need to be used carefully both in pets and in humans.
Following supply issues over the past 12 months, the company has gained regulatory approval to begin supplying Aqupharm through a new manufacturer.
Will Peel, marketing manager at Animalcare said: "We are aware of the challenges vets have faced over the past 12 months due to the shortage in supply, so we have been working hard to manage stock availability, however we are pleased that we are now able to supply the product on demand.
"We’d like to thank all our customers and wholesalers for their support and patience over the past year."
All existing Aqupharm products are available to order except Aqupharm no.3 which has been discontinued due to low market demand.
For product advice, contact: technical@animalcare.co.uk.
For further information or for orders, contact your local Animalcare Territory Manager or email animalcare@animalcare.co.uk.
https://www.aqupharm.co.uk
Virbac has announced that it is to increase production of cat vaccines at its French plants to help practices in the UK manage a shortfall in supply.
The predicted shortfall follows warnings by other manufacturers of stock shortages of between three and six months.
Virbac, which makes the Feligen RCP, Leucogen and Leucofeligen cat vaccines, says it wants to reassure practices that it will do its utmost to ensure continuity of supply during this period and is urging them to order as usual and not stockpile product, which could exacerbate the problem.
Simon Boulton MRCVS, Product Manager for Virbac's vaccine range, said: "Our priority is to keep stock flowing to our existing customers. With this in mind, we've now ceased to supply wholesalers with our cat vaccines. Once wholesaler stocks have been depleted, we ask customers to contact us directly so that stock can be despatched to them from our own warehouse.
By taking this step, we can manage our own stocks effectively and, while we'll be putting our existing customers first, we also stand ready to help supply the rest of the veterinary sector during this period. As a primary manufacturer of vaccines, we're well placed to react quickly to stock shortages and expect to have significantly increased supply by November."
Practices wanting further information should contact their Virbac Territory Manager. Direct orders to the company should be made by calling Virbac on 01359 243243 and selecting Option Three (Direct Orders).
Nigel Gibben said: "The Prevention Zone means anyone who keeps poultry such as chickens, ducks and geese, even as pets, must take action to stop them coming into contact with wild birds to protect them from avian flu.
"Birds should be moved into a suitable building, or if that isn’t possible owners must take sensible precautions to keep them away from wild birds, like putting up netting to create a temporary enclosure and keeping food and water supplies inside where they cannot be contaminated by wild birds.
"Even when birds are kept indoors a risk of infection remains so keepers must also practice good biosecurity, for example by disinfecting footwear and equipment and washing clothing after contact with birds.
"Recent H5N8 avian flu findings in wild birds and a backyard flock in Wales highlight just how essential it is to minimise contact between wild and captive birds and maintain good biosecurity to reduce the risk of infection.
"We must continue to be vigilant and do all we can to protect against this highly pathogenic strain of the disease, which is why we are extending the Prevention Zone, have introduced a ban on poultry gatherings and continue to strengthen surveillance to understand the extent of infection in wild birds."
The device emits low dose 265 nanometre (nm) ultraviolet C light at a targeted area.
In a 2022 in vitro / ex vivo study to evaluate the therapeutic potential of 265nm UVC for infectious keratitis1, UVC was found to inhibit all tested bacteria and fungi, including mixed culture and strains linked to antibiotic resistance.
In the study, no evidence of infection was found from 4 hours onwards, ulcers responded significantly in under 24 hours, and at the end point, those treated with UVC performed as as well as those treated with ciprofloxacin.
Photon Therapeutics says that in simple cases, one five-second treatment will suffice, but more complex cases can be re-treated after 24 hours.
Currently, there are two main barriers to the successful treatment of eye infections in dogs.
The first is the difficulty diagnosing the infection and identifying the right antimicrobial to use, highlighted by a 2017 study: Bacterial Isolates from Canine External Ocular Disease and their Antimicrobial Sensitivities 2.
The second is whether the owner is able or willing to administer a topical treatment.
Here the evidence suggests that even when treatment is possible, people do not comply with clinical advice anything like as much as they claim.
Photon Therapeutics points to what it says is the nearest study there is, in which carers of young children with uveitis did not give the correct treatment in 75% of cases3.
If the device is as effective as claimed, then both these issues simply evaporate.
PhotonUVC costs £4,995.
https://photon-therapeutics.com
VetSurgeon.org product briefing: https://www.vetsurgeon.org/m/veterinary-product-briefing/138134
References
Launched in 2023 to address the growing need for skilled farm vets, the VetPartners Farm Academy was created to provide more opportunities for future vets to gain hands-on experience.
VetPartners Farm Director Ian Cure said: “By opening up on-farm and simulated farm experiences to students, the academy aims to bridge the gap between veterinary education and practical farm work – ensuring a strong pipeline of talent into the industry.
“Designed by farm vets, for vets of the future, our three-day academy complements university education by providing veterinary students with a structured on-farm experience that builds confidence and prepares them for a career in farm practice.
“By welcoming students into the Farm Academy, we’re helping them develop the practical skills, confidence and knowledge needed to thrive in farm animal practice from day one.
"The academy also offers those students who haven’t had previous farm exposure the chance to try farm vetting for the first time.
“With the agricultural sector facing increasing pressures, from sustainability targets to animal health challenges, ensuring the next generation of farm vets is well-prepared is more important than ever.”
This year’s academy will take place at a VetPartners practice in Cornwall, from 14th to 16th June.
Students will receive training from experienced farm vets, and gain valuable skills in herd health, disease management, and sustainable livestock production.
The Farm Academy programme in 2025 will offer students:
To apply, send a CV and covering letter to farmsupport@vetpartners.co.uk
Applications close 25th April.
Intervet/Schering-Plough has announced that the license for Leptavoid-H has been improved allowing concurrent use with Bovilis BVD.
Intervet/Schering Plough says that given both vaccines are typically administered in the busy pre-turnout period, this will ease on-farm workload and should help to ensure that all primary courses or boosters take place sufficiently in advance of the period of risk.
Each vaccine is to be given by separate routes and sites, to animals of 8 months or older. The concurrent use in cattle may result in fewer animal interventions, less stress and better welfare.
The studies, undertaken by Intervet/Schering Plough's R&D division in the UK, focussed on both the safety and efficacy aspects of the concurrent administration of Leptavoid-H with Bovilis BVD. The company says no systemic adverse events occurred, there was no effect on the outcome of pregnancy or milk yields and the efficacy in cattle was not compromised.
Leptavoid-H is licensed to reduce the shedding of Leptospira interrogans serovar hardjo in urine. Leptavoid-H is the only Leptospirosis vaccine licensed to improve herd fertility when Leptospira hardjo is the cause of herd infertility, and the only vaccine proven to protect stock against both strains in the UK.
A collaborative team of researchers from the Waltham Centre for Pet Nutrition has shown that adding moisture to a cat's diet leads to an increase in activity and may help slow down weight gain.
In a series of studies conducted in partnership with the University of Aberdeen, Waltham scientists found that cats fed a dry diet with added water were more physically active and gained less weight than those cats fed the dry diet alone. According to the Centre, this is the first time reduced energy density diets have been associated with an increase in physical activity levels in cats.
Waltham scientist and author of the study, Dr. Penelope Morris, said: "These findings advance our understanding of the factors that influence body weight in cats and provide a strong basis for further research.
"Obesity is a growing problem in the cat population, recent figures indicate that up to 50 per cent of cats are either overweight or obese. These findings could have important implications for developing tailored diets that meet cats' energy and nutritional needs."
The research is part of a wider programme of ongoing collaborative research into the effect of food and nutrition on body weight in both cats and dogs.
The research has been published in the June edition (Volume 95, Issue 3) of the Journal of Animal Physiology and Animal Nutrition and is available in print and online: http://onlinelibrary.wiley.com/doi/10.1111/j.1439-0396.2010.01107.x/abstract